Objective. The study aimed to determine the increase in the yield of cervical intraepithelial neoplasia 3 (CIN 3) or cancer (CIN 3+) from random cervical biopsy in quadrants without visible lesions and endocervical curettage (ECC) in a low-prevalence setting. Results. Between January 1, 2007, and December 31, 2009, 4677 women with median age 32 years had 4932 colposcopies in the SCPMG-Fontana colposcopy clinics. Cervical intraepithelial neoplasia 3+ was diagnosed in 295 women. Cervical biopsy detected 64.4% of CIN 3+; ECC diagnosed 5.1%; loop electrocautery excision procedure (LEEP) or cervical conization for cervical biopsy and/or ECC of CIN 2 diagnosed 27.8%; LEEP for the cytology of highgrade squamous intraepithelial lesion with cervical biopsy result of negative or CIN 1 diagnosed 1.4%; and LEEP, cervical conization, or biopsy in follow-up of CIN 2 diagnosed 1.4%. Sixty-one of the 295 cases of CIN 3+ (20.7%) were diagnosed after evaluation of random cervical biopsy and/ or ECC of CIN 2+.
R ecently, we reported that the yield of cervical intraepithelial neoplasia 3 (CIN 3) or cancer (CIN 3+) per colposcopy increased from 10.2% for colposcopically directed biopsy alone to 14.3%, with p G .001, when random cervical biopsies at the squamocolumnar junction in cervical quadrants without visible lesions were added to colposcopically directed biopsy. There was a further increase in the yield of CIN 3+ per colposcopy to 16.1%, with p G .001, when endocervical curettage (ECC) was added to random biopsies [1] . This report was based on a review of 2 cross-sectional cervical cancer screening studies conducted in rural China in which the prevalence of CIN 3+ (2.33%) and of invasive cancer (0.32%) were high [2, 3] . We reviewed the colposcopy clinic experience in the clinics of the Southern California Permanente Group (SCPMG)-Fontana, CA, to determine whether random cervical biopsy and ECC are as effective in increasing the yield of CIN 3+ per colposcopy in an area with a low prevalence of CIN 3+.
MATERIALS AND METHODS
Since 1996, the SCPMG-Fontana colposcopy clinic records have been stored electronically in a FileMaker Pro file (FileMaker, Inc., Santa Clara, CA). Since 2004, in the SCPMG-Fontana colposcopy clinics, random biopsies at the squamocolumnar junction in cervical quadrants without visible lesions have been obtained in addition to colposcopically directed biopsies. The colposcopically directed biopsies and random biopsies were placed in the same jar of fixative. Moreover, since 2004, ECC has been obtained at colposcopy in women that were not pregnant. We reviewed the FileMaker Pro files for the SCPMG-Fontana colposcopy clinics for the 3-year period January 1, 2007, to December 31, 2009, to determine the method of diagnosis of CIN 3+. One of the authors (F.A.) reviewed the histological slides with CIN 3+ to confirm the diagnosis. This review of previously collected data was approved by the SCPMG Institutional Review Board. Trends were tested with the Cochran-Armitage trend test. Differences in independent proportions were tested with W 2 . A p G .05 was assumed to be significant. Data were analyzed using SAS version 9.1.3 (SAS Institute, Cary, NC).
RESULTS
Between January 1, 2007, and December 31, 2009, in SCPMG-Fontana, 124,750 women age 16 to 75 years or older were screened for cervical cancer prevention with conventional dry-slide cervical cytology and 80,414 women, mostly 30 years or older, were screened with endocervical high-risk human papillomavirus (HR-HPV) tests (Hybrid Capture 2; Qiagen, Corp., Germantown, MD). Within this 3-year period, 4677 women with median age 32 years had 4932 colposcopies. Of these 4932 colposcopies, 4635 were performed for evaluation of abnormal cervical cytology and/or positive results for HR-HPV tests, cervical lesions, or postcoital bleeding. The remaining 288 colposcopies were repeat colposcopies done postpartum or in follow-up of treated or untreated CIN 2 or CIN 3. Table 1 . The most common indications for colposcopy were evaluation of women with cervical cytology of lowgrade squamous intraepithelial lesion (LSIL) or cytology of atypical squamous cells of undetermined significance (ASCUS) with a positive result for HR-HPV. Women who are negative for cytological diagnosis and positive for HR-HPV were referred for colposcopy if they had a history of having an abnormal result for cervical cytology, HR-HPV, or CIN or if repeat screening at 12 and 24 months was still negative for cytology with a positive result for HR-HPV, and women with cytology of ASCUS with negative result for HR-HPV were referred for colposcopy if repeat screening at 12 months was still ASCUS with negative result for HR-HPV.
Of the 4635 women evaluated for cervical cytology with abnormal result and/or positive result for HR-HPV tests, 274 (5.9%) were diagnosed with CIN 3 and 21 (0.5%) were diagnosed with invasive cancer. The most common type of biopsy diagnosing CIN 3+ was cervical biopsy, either colposcopically directed or random with or without an ECC showing CIN 3+, which was found in 64.4% (190/295) of cases (see Table 2 ).
The second most common type of biopsy diagnosing CIN 3+ was loop electrocautery excision procedure (LEEP) or cervical conization (cone) done in the evaluation of women with cervical biopsy and/or ECC showing CIN 2; this was found in 27.8% (82/295) of women. In the 3-year period of this review, 379 women had colposcopy with worst histological diagnosis by cervical biopsy and/or ECC of CIN 2. Of these 379 women, 274 were immediately evaluated with LEEP or cone, 85 young (median age = 22 y) mostly nulliparous women were followed up with colposcopy and biopsy every 6 months, 11 were reevaluated postpartum, and 9 were lost to follow- up. Of the 274 women immediately evaluated with LEEP or cone, 82 were diagnosed with CIN 3+; of the 85 women that were followed up, 4 were diagnosed with CIN 3; and of the 11 women reevaluated postpartum, none were diagnosed with CIN 3+. Only 4 women (1.4%) were diagnosed with CIN 3+ by LEEP or cone done for evaluation of a discordant cervical cytology of high-grade squamous intraepithelial lesion (HSIL), adenocarcinoma in situ (AIS), or cancer associated with cervical biopsy and/or ECC of negative result or HPV.
Further insight into the type of biopsy (cervical and/or ECC) leading to the diagnosis of CIN 3+ can be obtained by stratifying the women with CIN 3+ by colposcopic impression and cervical cytology. The 108 women with CIN 3+ that had cervical cytology of HSIL, AIS, or cancer are shown in Table 3A , whereas the 187 women with cytology other than HSIL, AIS, or cancer are shown in Table 3B. Within Tables 3A and 3B , there are 11 women with missing ECC and 3 with missing cervical biopsy that were coded respectively as negative for ECC and negative for cervical biopsy. Of the 295 women with a final diagnosis of CIN 3+, 107 had cervical biopsy and ECC of CIN 2, CIN 3, or cancer (CIN 2+), 158 had cervical biopsy of CIN 2+ with CIN 1 or a negative result for ECC, 26 had CIN 1 or negative result for cervical biopsy with CIN 2+ result for ECC, and 4 had negative result or CIN 1 for cervical biopsy and ECC (these are the same 4 women from the fourth line of Table 2 that were diagnosed by LEEP or cone performed because their cervical cytology was HSIL, AIS, or cancer). If we assume that the 108 women in Table 3A would have had colposcopically directed cervical biopsy showing CIN 2+ or would have had LEEP or cone for discordant cytology of HSIL, AIS, or cancer associated with colposcopically directed biopsy with negative result or HPV, then these 108 women might have been diagnosed without the addition of random biopsy and/or ECC. Of the 187 women in Table 3B with cytology other than HSIL, AIS, or cancer, 22 had colposcopic impressions of CIN 2, CIN 3, or cancer and also might have been diagnosed by LEEP or cone even if the result for colposcopically directed biopsy was negative or CIN 1. The additional cases of CIN 3+ from random biopsy and ECC are seen among the 61 women with cervical cytology other than HSIL, AIS, or cancer with normal colposcopic impressions in all 4 cervical quadrants (see fifth row of data in Table 3B ) and among the 91 women with cervical cytology other than HSIL, AIS, or cancer with colposcopic impressions of CIN 1 or HPV (see fourth row of data in Table 3B ). If colposcopically directed biopsy was augmented by random biopsy but not by ECC, 51 of the 61 women with negative colposcopic impressions and cervical cytology other than HSIL, AIS, or cancer would have been diagnosed with CIN 3+; if colposcopically directed biopsy was augmented by ECC but not by random biopsy, 33 of these 61 women would have been diagnosed; and if colposcopically directed biopsy was augmented by both random biopsy and ECC, all 61 would have been diagnosed. The importance of random biopsy in the 91 women with cervical cytology other than HSIL, AIS, or cancer that had at least 1 cervical quadrant with a colposcopic impression of CIN 1 or HPV is hampered by our inability Tables 3A and  3B second column of data). As noted in the previous paragraph, the 7 women in Table 3A that were diagnosed by an ECC showing CIN 2+ with a negative result or HPV for cervical biopsy might have been diagnosed even if the ECC were not done if LEEP or cone was done for discordant cytology and biopsy, and the 1 of the 18 women in Table 3B diagnosed because of evaluation of an ECC of CIN 2+ might have been diagnosed because of LEEP or cone for discordant colposcopic impression of CIN 3 with a negative result or CIN 1 for biopsy. As such, one could argue that only 17 (5.8%) of the 295 women with CIN 3+ were diagnosed solely because of an ECC of CIN 2+. As shown in Table 4 , the proportion of women with CIN 3+ and an ECC of CIN 2+ increased because the woman's age increased from 11.1% in women age 16 to 24 years to 83.3% in women age 55 years or older (trend, p G .001). None of the 36 women with CIN 3+ who were age 16 to 24 years was diagnosed solely because her ECC was CIN 2+.
The Table 5 ).
DISCUSSION
We showed in the review of a colposcopy experience in China that colposcopically directed biopsy misses approximately a third of CIN 3+ [1] . This rate of missed CIN 3+ has been corroborated by Stoler et al. [4] who found that colposcopically directed biopsy diagnosed approximately half of the CIN 3+ found in same-day LEEP specimens. In our matched comparison, the proportion of women with a cervical biopsy showing CIN 3+ and normal colposcopic impressions in all 4 quadrants and the proportion of women with CIN 3+ diagnosed by an ECC showing CIN 3+ were similar in the China and Fontana series suggesting that the accuracy of colposcopy in Fontana 2007 to 2009 is similar to that in our China reviews. The conclusion that the accuracy of colposcopy in Fontana 2007 to 2009 is similar to that in our China series is important as it suggests that the relationships among lesion size, cervical cytology, and accuracy of colposcopy found in China [1] are likely present in Fontana. The current Fontana 2007 to 2009 colposcopy review differs from our previous reviews in China in that the Fontana 2007 to 2009 review includes 90 women diagnosed with CIN 3+ by LEEP, cone, or hysterectomy after colposcopy with cervical biopsy and/or ECC of CIN 2 or with discordant cervical cytology of HSIL, AIS, or cancer associated with cervical biopsy and/or ECC with a negative result or CIN 1. The Fontana series also differs from the China series in that the age range in the Fontana review (16Y75 y or older) is much greater than in the China series (35Y50 y) and the yield of CIN 3+ per colposcopy in the Fontana review (6.4%, 295/4635) is lower than in the China series (16.1%, 222/1383, p G .001) [1] . In the current review, adding random biopsy alone to colposcopically directed biopsy diagnosed at least an additional 51 cases of CIN 3+, adding ECC alone to colposcopically directed biopsy diagnosed at least an additional 33 cases of CIN 3+, and adding both random biopsy and ECC to colposcopically directed biopsy diagnosed at least an additional 61 cases of CIN 3+. These additional cases of CIN 3+ diagnosed by random biopsy and ECC are made on the 61 women with cervical cytology other than HSIL, AIS, or cancer that had negative colposcopic impressions in all 4 cervical quadrants (see fifth line of Table 3B ). They do not include the 14 women with cervical cytology of HSIL, AIS, or cancer that had negative colposcopic impressions (see fifth row of data in Table 3A because we assumed that these women would undergo LEEP or cone for discordant cytology of HSIL, AIS, or cancer associated with negative colposcopic impression, and they do not include the women with a negative result or CIN 1 for colposcopically directed biopsy that have a random biopsy or ECC showing CIN 2+. This occurred in the review of the China colposcopy experience in which 23 of the 81 women not diagnosed with CIN 3+ by a colposcopically directed biopsy had at least 1 cervical quadrant with a colposcopic impression of HPV, CIN, or cancer [1] .
We cannot measure the yield of colposcopically directed biopsy and random biopsy but, if the distribution of colposcopically directed biopsy and random biopsy in Fontana is similar to China, the yield of women with CIN 3+ per random biopsy in the Fontana series would be approximately 0.5%. In part, this low yield is secondary to the low yield of CIN 3+ per colposcopy in the Fontana 2007 to 2009 series (6.4%), and in part, it is secondary to the fact that colposcopically directed biopsy is 8 to 12 times (depending on how the calculations are done) more likely to show CIN 3+ than is random biopsy [1] . The low yield of CIN 3+ per random biopsy would be a greater problem if the random biopsies were difficult to perform, particularly morbid, or difficult to interpret. If the biopsies are done with a 2-mm bronchoscopy biopsy instrument, they are easy to perform, do not cause much discomfort, are large enough to diagnose CIN (the average thickness of CIN 2 and 3 is 290 Hm [5] ), and are easy to interpret.
Our Of interest is the ancillary finding that 27.8% of the CIN 3+ in this review was diagnosed by LEEP or cone after a cervical biopsy and/or ECC showing CIN 2. Recent data suggests that approximately 40% of CIN 2 resolves spontaneously [6] . Given that much of CIN 2 resolves, there is an implicit recommendation to perform LEEP or cone for treatment of CIN 2 with some reluctance. In this series, follow-up with 6-monthly colposcopy for women with CIN 2 was performed for young nulliparous women. With this selection, only 4 cases of CIN 3+ and no cases of cancer were diagnosed among 85 such women. This suggests that following up young nulliparous women with CIN 2 is a reasonable alternative to immediate LEEP or cone. Selection criteria for follow-up versus immediate LEEP or cone for the older parous women might include the associated cervical cytology, age, HPV genotype, or presence of immunostaining for p16. This is the subject of another manuscript.
The strengths of this study are that it is large, that the endpoint was CIN 3+, and that the pathology of CIN 3+ was confirmed. The weakness is that, except for the 75 women with normal colposcopic impressions in all 4 quadrants (in whom the cervical biopsies were all random), it is not possible to tell how many random versus colposcopically directed biopsies were performed and which cervical biopsy resulted in the diagnosis of CIN 3+. Regardless, we showed that when colposcopically directed
